{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:33:25Z","timestamp":1791203605610,"version":"4.2.0"},"reference-count":105,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2012,11,20]],"date-time":"2012-11-20T00:00:00Z","timestamp":1353369600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1001347","type":"journal-article","created":{"date-parts":[[2012,11,20]],"date-time":"2012-11-20T17:19:06Z","timestamp":1353431946000},"page":"e1001347","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":173,"title":["Population Health Impact and Cost-Effectiveness of Tuberculosis Diagnosis with Xpert MTB\/RIF: A Dynamic Simulation and Economic Evaluation"],"prefix":"10.1371","volume":"9","author":[{"given":"Nicolas A.","family":"Menzies","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsien-Ho","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,11,20]]},"reference":[{"key":"ref1","unstructured":"World Health Organization (2011) Global tuberculosis control: WHO report 2011. Geneva: World Health Organization."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e1721","DOI":"10.1371\/journal.pone.0001721","article-title":"Has the DOTS strategy improved case finding or treatment success? An empirical assessment","volume":"3","author":"Z Obermeyer","year":"2008","journal-title":"PLoS ONE"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1473-3099(11)70257-2","article-title":"Point-of-care tuberculosis diagnosis: are we there yet?","volume":"12","author":"CM Denkinger","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/archinte.163.9.1009","article-title":"The growing burden of tuberculosis: global trends and interactions with the HIV epidemic","volume":"163","author":"EL Corbett","year":"2003","journal-title":"Arch Intern Med"},{"key":"ref5","first-page":"1","article-title":"The impact of human immunodeficiency virus on presentation and diagnosis of tuberculosis in a cohort study in Zambia","volume":"96","author":"AM Elliott","year":"1993","journal-title":"J Trop Med Hyg"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/S0140-6736(07)60284-0","article-title":"Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes","volume":"369","author":"H Getahun","year":"2007","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1086\/590010","article-title":"Cost-effectiveness analysis of introduction of rapid, alternative methods to identify multidrug-resistant tuberculosis in middle-income countries","volume":"47","author":"C Acuna-Villaorduna","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref8","first-page":"131","article-title":"Diagnosis of drug-resistant tuberculosis: reliability and rapidity of detection","volume":"14","author":"A Van Deun","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/CMR.00059-10","article-title":"Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities","volume":"24","author":"LM Parsons","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"ref10","first-page":"355","article-title":"Tuberculosis bacteriology\u2014priorities and indications in high prevalence countries: position of the technical staff of the Tuberculosis Division of the International Union Against Tuberculosis and Lung Disease","volume":"9","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref11","first-page":"869","article-title":"The dilemma of MDR-TB in the global era","volume":"2","author":"P Farmer","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1471-2334-8-72","article-title":"Patient and provider delay in tuberculosis suspects from communities with a high HIV prevalence in South Africa: a cross-sectional study","volume":"8","author":"G Meintjes","year":"2008","journal-title":"BMC Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/S0140-6736(06)69575-5","article-title":"XDR tuberculosis: an indicator of public-health negligence","volume":"368","author":"A Van Rie","year":"2006","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa0907847","article-title":"Rapid molecular detection of tuberculosis and rifampin resistance","volume":"363","author":"CC Boehme","year":"2010","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(11)60438-8","article-title":"Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB\/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study","volume":"377","author":"CC Boehme","year":"2011","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/JCM.01463-09","article-title":"Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology","volume":"48","author":"D Helb","year":"2010","journal-title":"J Clin Microbiol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1164\/rccm.201101-0056OC","article-title":"Evaluation of the Xpert MTB\/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting","volume":"184","author":"G Theron","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e20458","DOI":"10.1371\/journal.pone.0020458","article-title":"Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB\/RIF assay\u2014a clinical validation study","volume":"6","author":"A Rachow","year":"2011","journal-title":"PLoS ONE"},{"key":"ref19","unstructured":"Selibas K, Hanrahan C, Deery C, Dansey H, Clouse K, <etal>et al<\/etal>.. (2012) TB suspects with negative initial Xpert [abstract]. 3rd South African Tuberculosis Conference; 12\u201315 June 2012; Durban, South Africa."},{"key":"ref20","unstructured":"World Health Organization (2010) Roadmap for rolling out Xpert MTB\/RIF for rapid diagnosis of TB and MDR-TB. Geneva: World Health Organization."},{"key":"ref21","unstructured":"World Health Organization (2012) WHO monitoring of Xpert MTB\/RIF roll-out: orders of GeneXperts and Xpert MTB\/RIF cartridges [database]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.stoptb.org\/wg\/gli\/assets\/documents\/map\/1\/atlas.html\" xlink:type=\"simple\">http:\/\/www.stoptb.org\/wg\/gli\/assets\/documents\/map\/1\/atlas.html<\/ext-link>. Accessed 4 September 2012. Geneva: World Health Organization."},{"key":"ref22","unstructured":"Mirzayev F (2012) Current dynamics in the Xpert MTB\/RIF assay pricing mechanisms [abstract]. Xpert MTB\/RIF Early Implementers Meeting; 18\u201319 April 2012; Annecy, France. Geneva: World Health Organization."},{"key":"ref23","unstructured":"Cepheid Pharmaceuticals (2012 Aug 6) Cepheid announces first phase of Xpert MTB\/RIF buy-down for high burden developing countries. Sunnyvale (California): Cepheid Pharmaceuticals."},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e1001063","DOI":"10.1371\/journal.pmed.1001063","article-title":"Is scale-up worth it? Challenges in economic analysis of diagnostic tests for tuberculosis","volume":"8","author":"DW Dowdy","year":"2011","journal-title":"PLoS Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e1001064","DOI":"10.1371\/journal.pmed.1001064","article-title":"GeneXpert\u2014a game-changer for tuberculosis control?","volume":"8","author":"CA Evans","year":"2011","journal-title":"PLoS Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4269\/ajtmh.2012.12-0107","article-title":"Rapid implementation of new tb diagnostic tests: is it too soon for a global roll-out of Xpert MTB\/RIF?","volume":"87","author":"DE Kirwan","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e1001067","DOI":"10.1371\/journal.pmed.1001067","article-title":"Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB\/RIF assay: a prospective study","volume":"8","author":"SD Lawn","year":"2011","journal-title":"PLoS Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e1001061","DOI":"10.1371\/journal.pmed.1001061","article-title":"Comparison of Xpert MTB\/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study","volume":"8","author":"LE Scott","year":"2011","journal-title":"PLoS Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.5588\/ijtld.11.0392","article-title":"Xpert(R) MTB\/RIF for national tuberculosis programmes in low-income countries: when, where and how?","volume":"15","author":"A Trebucq","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"206","DOI":"10.5588\/ijtld.11.0395","article-title":"False-positive rifampicin resistance on Xpert(R) MTB\/RIF: case report and clinical implications","volume":"16","author":"A Van Rie","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref31","first-page":"1506","article-title":"Assessing the impact of new diagnostics on tuberculosis control","volume":"14","author":"A Ramsay","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1183\/09031936.00145511","article-title":"Do adjunct tuberculosis tests, when combined with Xpert MTB\/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting?","volume":"40","author":"G Theron","year":"2012","journal-title":"Eur Respir J"},{"key":"ref33","unstructured":"World Health Organization (2011) Rapid implementation of the Xpert MTB\/RIF diagnostic test: technical and operational \u2018how-to\u2019. Geneva: World Health Organization."},{"key":"ref34","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/1471-2458-9-174","article-title":"Determinants of knowledge of HIV status in South Africa: results from a population-based HIV survey","volume":"9","author":"K Peltzer","year":"2009","journal-title":"BMC Public Health"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1136\/bmj.38645.660093.68","article-title":"Cost effectiveness analysis of strategies for tuberculosis control in developing countries","volume":"331","author":"R Baltussen","year":"2005","journal-title":"BMJ"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"7042","DOI":"10.1073\/pnas.0600349103","article-title":"Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations","volume":"103","author":"T Cohen","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2471\/BLT.08.054510","article-title":"The persistence of tuberculosis in the age of DOTS: reassessing the effect of case detection","volume":"87","author":"DW Dowdy","year":"2009","journal-title":"Bull World Health Organ"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/S0140-6736(98)03199-7","article-title":"Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy","volume":"352","author":"C Dye","year":"1998","journal-title":"Lancet"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"8180","DOI":"10.1073\/pnas.140102797","article-title":"Criteria for the control of drug-resistant tuberculosis","volume":"97","author":"C Dye","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"13881","DOI":"10.1073\/pnas.95.23.13881","article-title":"Modeling the impact of global tuberculosis control strategies","volume":"95","author":"CJ Murray","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e273","DOI":"10.1371\/journal.pmed.0030273","article-title":"Prospects for advancing tuberculosis control efforts through novel therapies","volume":"3","author":"JA Salomon","year":"2006","journal-title":"PLoS Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1056\/NEJM199201233260404","article-title":"An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms","volume":"326","author":"CL Daley","year":"1992","journal-title":"N Engl J Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0962-8479(95)90537-5","article-title":"Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in an immunocompetent patient","volume":"76","author":"RW Shafer","year":"1995","journal-title":"Tuber Lung Dis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00002030-199903110-00009","article-title":"Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials","volume":"13","author":"HC Bucher","year":"1999","journal-title":"AIDS"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"e1013","DOI":"10.1016\/j.ijid.2010.06.016","article-title":"Treatment outcomes of patients co-infected with HIV and tuberculosis who received a nevirapine-based antiretroviral regimen: a four-year prospective study","volume":"14","author":"W Manosuthi","year":"2010","journal-title":"Int J Infect Dis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1097\/00002030-200409240-00009","article-title":"Incidence of tuberculosis and survival after its diagnosis in patients infected with HIV-1 and HIV-2","volume":"18","author":"MA van der Sande","year":"2004","journal-title":"AIDS"},{"key":"ref47","first-page":"661","article-title":"Estimation of adult antiretroviral treatment coverage in South Africa","volume":"99","author":"MA Adam","year":"2009","journal-title":"S Afr Med J"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0140-6736(08)61697-9","article-title":"Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model","volume":"373","author":"RM Granich","year":"2009","journal-title":"Lancet"},{"key":"ref49","first-page":"738271","article-title":"Estimating the impact and cost of the WHO 2010 recommendations for antiretroviral therapy","volume":"2011","author":"J Stover","year":"2011","journal-title":"AIDS Res Treat"},{"key":"ref50","unstructured":"UNAIDS Reference Group on Estimates, Modelling and Projections (2011) Technical meeting to review Spectrum 2011 and considering potential bias in DHS and ANC data. Geneva: Joint United Nations Programme on HIV\/AIDS."},{"key":"ref51","first-page":"1021","article-title":"Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis","volume":"12","author":"DW Dowdy","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1080\/01621459.2000.10474324","article-title":"Inference for deterministic simulation models: the Bayesian melding approach","volume":"95","author":"D Poole","year":"2000","journal-title":"J Am Stat Assoc"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1080\/01621459.1995.10476529","article-title":"Inference from a deterministic population dynamics model for bowhead whales","volume":"90","author":"AE Raftery","year":"1995","journal-title":"J Am Stat Assoc"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"i11","DOI":"10.1136\/sti.2008.029991","article-title":"Bayesian melding for estimating uncertainty in national HIV prevalence estimates","volume":"84","author":"L Alkema","year":"2008","journal-title":"Sex Transm Infect"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1214\/07-AOAS111","article-title":"Probabilistic projections of HIV prevalence using Bayesian melding","volume":"1","author":"L Alkema","year":"2007","journal-title":"Ann Appl Stat"},{"issue":"Suppl 2","key":"ref56","doi-asserted-by":"crossref","first-page":"ii3","DOI":"10.1136\/sti.2010.044784","article-title":"Modelling HIV epidemics in the antiretroviral era: the UNAIDS Estimation and Projection package 2009","volume":"86","author":"T Brown","year":"2010","journal-title":"Sex Transm Infect"},{"key":"ref57","unstructured":"World Health Organization (2011) Tuberculosis (TB) [database]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/tb\/country\/data\/download\/en\/index.html\" xlink:type=\"simple\">http:\/\/www.who.int\/tb\/country\/data\/download\/en\/index.html<\/ext-link>. Accessed 30 September 2011. Geneva: World Health Organization."},{"key":"ref58","unstructured":"World Health Organization (2010) Multidrug and extensively drug-resistant TB (M\/XDR-TB): 2010 global report on surveillance and response. Geneva: World Health Organization."},{"key":"ref59","unstructured":"Rubin D (1988) Using the SIR algorithm to simulate posterior distributions. In: Bernardo JM, DeGroot MH, Lindley DV, Smith AFM, editors. Bayesian statistics 3. Oxford: Oxford University Press. pp. 395\u2013402."},{"key":"ref60","unstructured":"Joint United Nations Programme on HIV\/AIDS (2010) Towards universal access: scaling up priority HIV\/AIDS interventions in the health sector. Progress report 2010. Geneva: Joint United Nations Programme on HIV\/AIDS."},{"key":"ref61","unstructured":"World Health Organization (2006) Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach\u20142006 revision. Geneva: World Health Organization."},{"key":"ref62","unstructured":"World Health Organization (2010) Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach\u20142010 revision. Geneva: World Health Organization."},{"key":"ref63","unstructured":"World Health Organization (2011) Global price reporting mechanism for HIV, tuberculosis and malaria. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/hiv\/amds\/gprm\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/hiv\/amds\/gprm\/en\/<\/ext-link>. Accessed 21 May 2011. Geneva: World Health Organization."},{"key":"ref64","doi-asserted-by":"crossref","first-page":"e36966","DOI":"10.1371\/journal.pone.0036966","article-title":"The impact and cost of scaling up GeneXpert MTB\/RIF in South Africa","volume":"7","author":"G Meyer-Rath","year":"2012","journal-title":"PLoS ONE"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/j.1365-3156.2012.03028.x","article-title":"Scaling up Xpert MTB\/RIF technology: the costs of laboratory- vs. clinic-based roll-out in South Africa","volume":"17","author":"K Schnippel","year":"2012","journal-title":"Trop Med Int Health"},{"key":"ref66","unstructured":"Murray CJL, Lopez AD (1996) The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge (Massachusetts): Harvard University Press."},{"key":"ref67","unstructured":"World Health Organization (2004) Global burden of disease 2004 update: disability weights for diseases and conditions. Geneva: World Health Organization."},{"key":"ref68","unstructured":"Tan Torres T, Baltussen R, Adam T, Hutubessy R, Acharya A, <etal>et al<\/etal>.. (2003) Making choices in health: WHO guide to cost effectiveness analysis. Geneva: World Health Organization."},{"key":"ref69","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/jama.1996.03540150055031","article-title":"Recommendations of the Panel on Cost-effectiveness in Health and Medicine","volume":"276","author":"MC Weinstein","year":"1996","journal-title":"JAMA"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1478-7547-1-8","article-title":"Generalized cost-effectiveness analysis for national-level priority-setting in the health sector","volume":"1","author":"R Hutubessy","year":"2003","journal-title":"Cost Eff Resour Alloc"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/00224065.1981.11978748","article-title":"An approach to sensitivity analysis of computer models: part I\u2014introduction, input variable selection and preliminary variable assessment","volume":"13","author":"RL Iman","year":"1981","journal-title":"J Qual Technol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/00224065.1981.11978763","article-title":"An approach to sensitivity analysis of computer models: part II\u2014ranking of input variables, response surface validation, distribution effect, and technique synopsis variable assessment","volume":"13","author":"RL Iman","year":"1981","journal-title":"J Qual Technol"},{"key":"ref73","unstructured":"World Bank (2011) World development indicators 2011. Washington (District of Columbia): World Bank."},{"key":"ref74","unstructured":"National Health Laboratory Service (2012) Xpert testing algorithm. South Africa: National Health Laboratory Service."},{"key":"ref75","doi-asserted-by":"crossref","first-page":"19485","DOI":"10.1073\/pnas.1005660107","article-title":"Antiretroviral therapy for tuberculosis control in nine African countries","volume":"107","author":"BG Williams","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref76","unstructured":"Schnippel K, Rosen S, Shearer K, Martinson N, Long L, <etal>et al<\/etal>.. (2012) The cost of inpatient treatment for multi-drug resistant tuberculosis in South Africa [abstract]. International AIDS Economics Network 7th AIDS &amp; Economics Pre-Conference; 22\u201327 July 2012; Washington, District of Columbia, US."},{"key":"ref77","doi-asserted-by":"crossref","first-page":"e1001120","DOI":"10.1371\/journal.pmed.1001120","article-title":"Rapid diagnosis of tuberculosis with the Xpert MTB\/rif assay in high burden countries: a cost-effectiveness analysis","volume":"8","author":"A Vassall","year":"2011","journal-title":"PLoS Med"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/QAD.0b013e3283522d47","article-title":"The cost-effectiveness of routine tuberculosis screening with Xpert MTB\/RIF prior to initiation of antiretroviral therapy: a model-based analysis","volume":"26","author":"JR Andrews","year":"2012","journal-title":"AIDS"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1093\/cid\/cis190","article-title":"Increased and expedited case detection by Xpert MTB\/RIF assay in childhood tuberculosis: a prospective cohort study","volume":"54","author":"A Rachow","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/cid\/cis598","article-title":"Rapid molecular diagnosis of pulmonary tuberculosis in children using nasopharyngeal specimens","volume":"55","author":"HJ Zar","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1098\/rsif.2007.1138","article-title":"Eliminating human tuberculosis in the twenty-first century","volume":"5","author":"C Dye","year":"2008","journal-title":"J R Soc Interface"},{"key":"ref82","unstructured":"Frieden T (2004) Toman&apos;s tuberculosis: case detection, treatment and monitoring: questions and answers, 2nd edition. Geneva: World Health Organization."},{"key":"ref83","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1378\/chest.95.6.1193","article-title":"A reevaluation of sputum microscopy and culture in the diagnosis of pulmonary tuberculosis","volume":"95","author":"H Levy","year":"1989","journal-title":"Chest"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"11293","DOI":"10.1073\/pnas.0800965105","article-title":"Impact of enhanced tuberculosis diagnosis in South Africa: a mathematical model of expanded culture and drug susceptibility testing","volume":"105","author":"DW Dowdy","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/cid\/cir898","article-title":"AIDS and non-AIDS morbidity and mortality across the spectrum of CD4 cell counts in HIV-infected adults before starting antiretroviral therapy in Cote d&apos;Ivoire","volume":"54","author":"X Anglaret","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/S0140-6736(06)69117-4","article-title":"Short-term risk of AIDS or death in people infected with HIV-1 before antiretroviral therapy in South Africa: a longitudinal study","volume":"368","author":"M Badri","year":"2006","journal-title":"Lancet"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0140-6736(02)09411-4","article-title":"Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies","volume":"360","author":"M Egger","year":"2002","journal-title":"Lancet"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/QAD.0b013e328133f285","article-title":"Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies","volume":"21","author":"M May","year":"2007","journal-title":"AIDS"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00002030-200401020-00006","article-title":"Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drug-naive individuals and those treated in the monotherapy era","volume":"18","author":"A Phillips","year":"2004","journal-title":"AIDS"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0140-6736(09)60612-7","article-title":"Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies","volume":"373","author":"JA Sterne","year":"2009","journal-title":"Lancet"},{"key":"ref91","first-page":"240","article-title":"Economic analysis of the diagnosis of smear-negative pulmonary tuberculosis in South Africa: incorporation of a new rapid test, FASTPlaqueTB, into the diagnostic algorithm","volume":"8","author":"H Albert","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref92","first-page":"S29","article-title":"Cost and cost-effectiveness of increased community and primary care facility involvement in tuberculosis care in Lilongwe District, Malawi","volume":"7","author":"K Floyd","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"528","DOI":"10.2471\/BLT.04.018606","article-title":"Costs of measures to control tuberculosis\/HIV in public primary care facilities in Cape Town, South Africa","volume":"84","author":"HP Hausler","year":"2006","journal-title":"Bull World Health Organ"},{"key":"ref94","first-page":"240","article-title":"Diagnosing HIV-associated tuberculosis: reducing costs and diagnostic delay","volume":"4","author":"CP Hudson","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref95","first-page":"S14","article-title":"Cost and cost-effectiveness of increased community and primary care facility involvement in tuberculosis care in Machakos District, Kenya","volume":"7","author":"B Nganda","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1164\/rccm.201004-0620OC","article-title":"Costs and consequences of additional chest x-ray in a tuberculosis prevention program in Botswana","volume":"183","author":"T Samandari","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1016\/S0140-6736(02)08830-X","article-title":"Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru","volume":"359","author":"PG Suarez","year":"2002","journal-title":"Lancet"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1471-2334-5-111","article-title":"The role and performance of chest X-ray for the diagnosis of tuberculosis: a cost-effectiveness analysis in Nairobi, Kenya","volume":"5","author":"MR van Cleeff","year":"2005","journal-title":"BMC Infect Dis"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1371\/journal.pmed.0030241","article-title":"Cost-effectiveness of treating multidrug-resistant tuberculosis","volume":"3","author":"SC Resch","year":"2006","journal-title":"PLoS Med"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1478-7547-1-3","article-title":"Econometric estimation of country-specific hospital costs","volume":"1","author":"T Adam","year":"2003","journal-title":"Cost Eff Resour Alloc"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1478-7547-7-6","article-title":"Cost estimates of HIV care and treatment with and without anti-retroviral therapy at Arba Minch Hospital in southern Ethiopia","volume":"7","author":"AD Bikilla","year":"2009","journal-title":"Cost Eff Resour Alloc"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1365-3156.2010.02640.x","article-title":"Costs of HIV\/AIDS outpatient services delivered through Zambian public health facilities","volume":"16","author":"JH Bratt","year":"2011","journal-title":"Trop Med Int Health"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/QAI.0b013e3180691115","article-title":"The evolving cost of HIV in South Africa: changes in health care cost with duration on antiretroviral therapy for public sector patients","volume":"45","author":"G Harling","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref104","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1097\/QAD.0b013e3283463eec","article-title":"The cost of providing comprehensive HIV treatment in PEPFAR-supported programs","volume":"25","author":"NA Menzies","year":"2011","journal-title":"AIDS"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1365-3156.2008.02114.x","article-title":"The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa","volume":"13","author":"S Rosen","year":"2008","journal-title":"Trop Med Int Health"}],"container-title":["PLoS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1001347","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T14:04:48Z","timestamp":1643637888000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1001347"}},"subtitle":[],"editor":[{"given":"Sydney","family":"Rosen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,11,20]]},"references-count":105,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2012,11,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1001347","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,20]]}}}